Tang Capital* acquires ALLK for $0.33/sh—a 52% premium to yesterday’s close: https://www.globenewswire.com/news-release/2025/04/02/3054176/0/en/Allakos-Inc-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-LLC-for-0-33-in-Cash-per-Share.html *a/k/a Concentra Biosciences.